BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18398653)

  • 1. Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain.
    Vendt BA; McKinstry RC; Ball WS; Kraut MA; Prior FW; Barton B; Casella JF; DeBaun MR
    J Digit Imaging; 2009 Jun; 22(3):326-43. PubMed ID: 18398653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of the silent cerebral infarct transfusion (SIT) trial.
    Casella JF; King AA; Barton B; White DA; Noetzel MJ; Ichord RN; Terrill C; Hirtz D; McKinstry RC; Strouse JJ; Howard TH; Coates TD; Minniti CP; Campbell AD; Vendt BA; Lehmann H; Debaun MR
    Pediatr Hematol Oncol; 2010 Mar; 27(2):69-89. PubMed ID: 20201689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
    DeBaun MR; Gordon M; McKinstry RC; Noetzel MJ; White DA; Sarnaik SA; Meier ER; Howard TH; Majumdar S; Inusa BP; Telfer PT; Kirby-Allen M; McCavit TL; Kamdem A; Airewele G; Woods GM; Berman B; Panepinto JA; Fuh BR; Kwiatkowski JL; King AA; Fixler JM; Rhodes MM; Thompson AA; Heiny ME; Redding-Lallinger RC; Kirkham FJ; Dixon N; Gonzalez CE; Kalinyak KA; Quinn CT; Strouse JJ; Miller JP; Lehmann H; Kraut MA; Ball WS; Hirtz D; Casella JF
    N Engl J Med; 2014 Aug; 371(8):699-710. PubMed ID: 25140956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity.
    Pegelow CH; Wang W; Granger S; Hsu LL; Vichinsky E; Moser FG; Bello J; Zimmerman RA; Adams RJ; Brambilla D;
    Arch Neurol; 2001 Dec; 58(12):2017-21. PubMed ID: 11735775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.
    King AA; Noetzel M; White DA; McKinstry RC; Debaun MR
    Pediatr Blood Cancer; 2008 Mar; 50(3):599-602. PubMed ID: 17985350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive loss of brain volume in children with sickle cell anemia and silent cerebral infarct: A report from the silent cerebral infarct transfusion trial.
    Darbari DS; Eigbire-Molen O; Ponisio MR; Milchenko MV; Rodeghier MJ; Casella JF; McKinstry RC; DeBaun MR
    Am J Hematol; 2018 Dec; 93(12):E406-E408. PubMed ID: 30264867
    [No Abstract]   [Full Text] [Related]  

  • 7. Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow.
    Ford AL; Ragan DK; Fellah S; Binkley MM; Fields ME; Guilliams KP; An H; Jordan LC; McKinstry RC; Lee JM; DeBaun MR
    Blood; 2018 Oct; 132(16):1714-1723. PubMed ID: 30061156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of detecting silent cerebral infarcts in pediatric sickle cell anemia.
    Liem RI; Liu J; Gordon MO; Vendt BA; McKinstry RC; Kraut MA; Strouse JJ; Ball WS; DeBaun MR
    J Child Neurol; 2014 Dec; 29(12):1685-91. PubMed ID: 24309240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.
    Hulbert ML; McKinstry RC; Lacey JL; Moran CJ; Panepinto JA; Thompson AA; Sarnaik SA; Woods GM; Casella JF; Inusa B; Howard J; Kirkham FJ; Anie KA; Mullin JE; Ichord R; Noetzel M; Yan Y; Rodeghier M; Debaun MR
    Blood; 2011 Jan; 117(3):772-9. PubMed ID: 20940417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.
    Pegelow CH; Macklin EA; Moser FG; Wang WC; Bello JA; Miller ST; Vichinsky EP; DeBaun MR; Guarini L; Zimmerman RA; Younkin DP; Gallagher DM; Kinney TR
    Blood; 2002 Apr; 99(8):3014-8. PubMed ID: 11929794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental findings on brain magnetic resonance imaging of children with sickle cell disease.
    Jordan LC; McKinstry RC; Kraut MA; Ball WS; Vendt BA; Casella JF; DeBaun MR; Strouse JJ;
    Pediatrics; 2010 Jul; 126(1):53-61. PubMed ID: 20547639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial.
    Hsu P; Gay JC; Lin CJ; Rodeghier M; DeBaun MR; Cronin RM
    Blood Adv; 2021 Dec; 5(23):5032-5040. PubMed ID: 34607344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive functioning and brain magnetic resonance imaging in children with sickle Cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease.
    Armstrong FD; Thompson RJ; Wang W; Zimmerman R; Pegelow CH; Miller S; Moser F; Bello J; Hurtig A; Vass K
    Pediatrics; 1996 Jun; 97(6 Pt 1):864-70. PubMed ID: 8657528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Automated Detection of Silent Cerebral Infarcts in Children and Young Adults With Sickle Cell Anemia.
    Chen Y; Wang Y; Phuah CL; Fields ME; Guilliams KP; Fellah S; Reis MN; Binkley MM; An H; Lee JM; McKinstry RC; Jordan LC; DeBaun MR; Ford AL
    Stroke; 2023 Aug; 54(8):2096-2104. PubMed ID: 37387218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium.
    Phillips S; Schlenz AM; Mueller M; Melvin C; Adams RJ; Kanter J;
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28569. PubMed ID: 32894002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of central nervous system disease from pediatric to young adulthood in sickle cell anemia.
    Champlin G; Hwang SN; Heitzer A; Ding J; Jacola L; Estepp JH; Wang W; Ataga KI; Owens CL; Newman J; King AA; Davis R; Kang G; Hankins JS
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2473-2479. PubMed ID: 34407676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke prevention trial in sickle cell anemia.
    Adams RJ; McKie VC; Brambilla D; Carl E; Gallagher D; Nichols FT; Roach S; Abboud M; Berman B; Driscoll C; Files B; Hsu L; Hurlet A; Miller S; Olivieri N; Pegelow C; Scher C; Vichinsky E; Wang W; Woods G; Kutlar A; Wright E; Hagner S; Tighe F; Waclawiw MA
    Control Clin Trials; 1998 Feb; 19(1):110-29. PubMed ID: 9492971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.